Local company receives premarket clearance on wound care product

The Omeza Collagen Matrix is the company's first medical prescription product.


  • By
  • | 10:07 a.m. September 13, 2021
  • | 0 Free Articles Remaining!
Courtesy. Pictured is Omeza Founder and CEO Tom Gardner.
Courtesy. Pictured is Omeza Founder and CEO Tom Gardner.
  • Manatee-Sarasota
  • Share

SARASOTA — Omeza, a Sarasota-based skin science company, announced that its Omeza Collagen Matrix (OCM) product was cleared through the FDA 510(k) premarket notification process.  

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content